deltatrials
Active Not Recruiting OBSERVATIONAL NCT04826705

A Study of Endovascular Treatment of Femoropopliteal Arterial Occlusive Lesion With Drug-Coated Balloon (PROMISING)

A Prospective, Multicenter, Observational Study of Short and Long-term Outcome in Endovascular Treatment of Femoropopliteal Arterial Occlusive Lesion With Drug-Coated Balloon (PROMISING Study)

Sponsor: Chengdu University of Traditional Chinese Medicine

Interventions Drug-coated Balloon
Updated 7 times since 2021 Last updated: Mar 2, 2024 Started: Feb 1, 2021 Primary completion: Feb 1, 2025 Completion: Feb 1, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04826705, this observational or N/A phase trial focuses on Angioplasty and Drug-coated Balloon and remains ongoing. Sponsored by Chengdu University of Traditional Chinese Medicine, it has been updated 7 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~May 2021 – ~Dec 2021 · 7 months · monthly snapshotRecruiting~Dec 2021 – ~Mar 2022 · 3 months · monthly snapshot~Mar 2022 – ~Dec 2022 · 9 months · monthly snapshotRecruiting~Dec 2022 – ~Apr 2024 · 16 months · monthly snapshotRecruiting~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotActive Not Recruiting

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Active Not Recruiting

  2. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting

  3. Apr 2024 — Jul 2024 [monthly]

    Active Not Recruiting

    Status: RecruitingActive Not Recruiting

  4. Dec 2022 — Apr 2024 [monthly]

    Recruiting

  5. Mar 2022 — Dec 2022 [monthly]

    Recruiting

Show 2 earlier versions
  1. Dec 2021 — Mar 2022 [monthly]

    Recruiting

  2. May 2021 — Dec 2021 [monthly]

    Recruiting

    First recorded

Feb 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Chengdu University of Traditional Chinese Medicine
  • First People's Hospital of Hangzhou
  • Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology
  • Qingdao University
  • RenJi Hospital
  • Second Affiliated Hospital of Suzhou University
  • Xuanwu Hospital, Beijing
  • Zhejiang University
Data source: Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology

For direct contact, visit the study record on ClinicalTrials.gov .